Zydus Gets 2 US FDA Observations For Ahmedabad Oncology Site

Zydus Lifesciences Ltd. on Wednesday said the US Food and Drug Administration has issued two observations for its oncology injectable facility located near Matoda, Ahmedabad. The company clarified that neither observation relates to data integrity.

The inspection was conducted between June 9 and June 18. Zydus said it will work closely with the US regulator to address and respond to the issues promptly.